TY - CHAP
T1 - Prostate Cancer Energetics and Biosynthesis
AU - Lin, Chenchu
AU - Salzillo, Travis C.
AU - Bader, David A.
AU - Wilkenfeld, Sandi R.
AU - Awad, Dominik
AU - Pulliam, Thomas L.
AU - Dutta, Prasanta
AU - Pudakalakatti, Shivanand
AU - Titus, Mark
AU - McGuire, Sean E.
AU - Bhattacharya, Pratip K.
AU - Frigo, Daniel
N1 - Funding Information:
We thank Kelly Kage (UT MD Anderson Cancer Center) for assistance with the figures. This work was supported by grants from the National Institutes of Health (R01CA184208 to D.E.F.; P50CA094056, U54CA151668 and R21CA185536 to P.B.), American Cancer Society (RSG-16-084-01-TBE to D.E.F.), an Institutional Research Grant (to P.B.), startup grants from the University of Texas MD Anderson Cancer Center (to P.B. and D.E.F.), a grant from the Gulf Coast Consortium (to P.B.) and generous philanthropic contributions to The University of Texas MD Anderson Moon Shots Program (to D.E.F.) and Koch Foundation Genitourinary Medical Oncology Funds (to P.B.). This work was also supported by an Antje Wuelfrath Gee and Harry Gee, Jr. Family Legacy Scholarship (to C.L.), an American Legion Auxiliary Fellowship (to D.A.), a CPRIT Research Training Grant Award (RP170067 to T.C.S.) and a GCC/Keck Center CCBTP postdoctoral fellowship (CPRIT RP170593 to S.P.). M.T. also acknowledges support from the Neubauer Family Foundation.
Publisher Copyright:
© Springer Nature Switzerland AG 2019.
PY - 2019
Y1 - 2019
N2 - Cancers must alter their metabolism to satisfy the increased demand for energy and to produce building blocks that are required to create a rapidly growing tumor. Further, for cancer cells to thrive, they must also adapt to an often changing tumor microenvironment, which can present new metabolic challenges (ex. hypoxia) that are unfavorable for most other cells. As such, altered metabolism is now considered an emerging hallmark of cancer. Like many other malignancies, the metabolism of prostate cancer is considerably different compared to matched benign tissue. However, prostate cancers exhibit distinct metabolic characteristics that set them apart from many other tumor types. In this chapter, we will describe the known alterations in prostate cancer metabolism that occur during initial tumorigenesis and throughout disease progression. In addition, we will highlight upstream regulators that control these metabolic changes. Finally, we will discuss how this new knowledge is being leveraged to improve patient care through the development of novel biomarkers and metabolically targeted therapies.
AB - Cancers must alter their metabolism to satisfy the increased demand for energy and to produce building blocks that are required to create a rapidly growing tumor. Further, for cancer cells to thrive, they must also adapt to an often changing tumor microenvironment, which can present new metabolic challenges (ex. hypoxia) that are unfavorable for most other cells. As such, altered metabolism is now considered an emerging hallmark of cancer. Like many other malignancies, the metabolism of prostate cancer is considerably different compared to matched benign tissue. However, prostate cancers exhibit distinct metabolic characteristics that set them apart from many other tumor types. In this chapter, we will describe the known alterations in prostate cancer metabolism that occur during initial tumorigenesis and throughout disease progression. In addition, we will highlight upstream regulators that control these metabolic changes. Finally, we will discuss how this new knowledge is being leveraged to improve patient care through the development of novel biomarkers and metabolically targeted therapies.
KW - AR
KW - Imaging
KW - Metabolism
KW - Prostate cancer
UR - http://www.scopus.com/inward/record.url?scp=85077480345&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85077480345&partnerID=8YFLogxK
U2 - 10.1007/978-3-030-32656-2_10
DO - 10.1007/978-3-030-32656-2_10
M3 - Chapter
C2 - 31900911
AN - SCOPUS:85077480345
T3 - Advances in Experimental Medicine and Biology
SP - 185
EP - 237
BT - Advances in Experimental Medicine and Biology
PB - Springer
ER -